Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game

The interaction between tumor progression and innate immune system has been well established in the last years. Indeed, several lines of clinical evidence indicate that immune cells such as tumor-associated macrophages (TAMs) interact with tumor cells, favoring growth, angiogenesis, and metastasis o...

Full description

Saved in:
Bibliographic Details
Main Authors: Paqui G. Través, Alfonso Luque, Sonsoles Hortelano
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/568783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548312481267712
author Paqui G. Través
Alfonso Luque
Sonsoles Hortelano
author_facet Paqui G. Través
Alfonso Luque
Sonsoles Hortelano
author_sort Paqui G. Través
collection DOAJ
description The interaction between tumor progression and innate immune system has been well established in the last years. Indeed, several lines of clinical evidence indicate that immune cells such as tumor-associated macrophages (TAMs) interact with tumor cells, favoring growth, angiogenesis, and metastasis of a variety of cancers. In most tumors, TAMs show properties of an alternative polarization phenotype (M2) characterized by the expression of a series of chemokines, cytokines, and proteases that promote immunosuppression, tumor proliferation, and spreading of the cancer cells. Tumor suppressor genes have been traditionally linked to the regulation of cancer progression; however, a growing body of evidence indicates that these genes also play essential roles in the regulation of innate immunity pathways through molecular mechanisms that are still poorly understood. In this paper, we provide an overview of the immunobiology of TAMs as well as what is known about tumor suppressors in the context of immune responses. Recent advances regarding the role of the tumor suppressor ARF as a regulator of inflammation and macrophage polarization are also reviewed.
format Article
id doaj-art-1aebc1f96c294c2cb057461fd2e584f7
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-1aebc1f96c294c2cb057461fd2e584f72025-02-03T06:14:16ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/568783568783Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the GamePaqui G. Través0Alfonso Luque1Sonsoles Hortelano2Molecular Neurobiology Laboratory, The Salk Institute, 10010 North Torrey Pines Road, San Diego, CA 92037, USAInstituto Nacional de Investigación Agraria y Alimentaria (INIA), Centro de Investigación en Sanidad Animal (CISA), Ctra. de Algete a El Casar s/n, Valdeolmos, 28130 Madrid, SpainUnidad de Inflamación y Cáncer, Área de Biología Celular y Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda-Pozuelo, Km 2,200, Majadahonda, 28220 Madrid, SpainThe interaction between tumor progression and innate immune system has been well established in the last years. Indeed, several lines of clinical evidence indicate that immune cells such as tumor-associated macrophages (TAMs) interact with tumor cells, favoring growth, angiogenesis, and metastasis of a variety of cancers. In most tumors, TAMs show properties of an alternative polarization phenotype (M2) characterized by the expression of a series of chemokines, cytokines, and proteases that promote immunosuppression, tumor proliferation, and spreading of the cancer cells. Tumor suppressor genes have been traditionally linked to the regulation of cancer progression; however, a growing body of evidence indicates that these genes also play essential roles in the regulation of innate immunity pathways through molecular mechanisms that are still poorly understood. In this paper, we provide an overview of the immunobiology of TAMs as well as what is known about tumor suppressors in the context of immune responses. Recent advances regarding the role of the tumor suppressor ARF as a regulator of inflammation and macrophage polarization are also reviewed.http://dx.doi.org/10.1155/2012/568783
spellingShingle Paqui G. Través
Alfonso Luque
Sonsoles Hortelano
Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
Mediators of Inflammation
title Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
title_full Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
title_fullStr Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
title_full_unstemmed Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
title_short Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
title_sort macrophages inflammation and tumor suppressors arf a new player in the game
url http://dx.doi.org/10.1155/2012/568783
work_keys_str_mv AT paquigtraves macrophagesinflammationandtumorsuppressorsarfanewplayerinthegame
AT alfonsoluque macrophagesinflammationandtumorsuppressorsarfanewplayerinthegame
AT sonsoleshortelano macrophagesinflammationandtumorsuppressorsarfanewplayerinthegame